Global Digital Therapeutics Market Size & Share (2021 - 2028) Will Reach USD 13.51 Billion, at 26.1% CAGR: Polaris Market Research

According to the research report, the global digital therapeutics market was valued at USD 2.18 billion in 2020 and is expected to reach USD 13.51 Billion By 2028, growing at a CAGR of 26.1% during the forecast period.

The distinction between digital therapeutics is determined by patient clinical outcomes. Digital therapeutics do not use market-based health-related instruments like step and calorie-counters. It is a modern form of healthcare product that utilizes digital technologies to avoid, handle, and health ailments. Furthermore, it makes use of emerging health technology to treat the psychiatric ailment. As a result, the aforementioned factors contribute to the growth of the target market share.

Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Top Market Players Are:

Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.

During the year 2020, digital health went from innovation to need. As acceptance peaked, exacerbated by the COVID-19 pandemic, it swept into almost every healthcare domain. Telehealth, digital pathology, triage solutions, telemedicine, mhealth, and digital therapeutics were among the topics discussed.

Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/8751

Omada Health, Inc., took advantage of the shortages in treatment caused by COVID-19 to offer additional help and advice through its dedicated practitioners to those whose doctor's appointments had been postponed indefinitely.

Additionally, the organization assisted primary care practitioners, psychiatrists, endocrinologists, and cardiologists in converting their practices to telehealth through providing improved knowledge, psychosocial support, and an online platform.

The FDA issued recommendations extending and encouraging the scope of digital health therapeutics technologies for mental health issues in response to COVID-19 and its ramifications on mental health. Another factor expected to drive demand growth is increased public and private sector initiatives. For example, Akili Interactive Labs, Inc. obtained the CE mark for EndeavorRx, its digital therapeutics software for the treatment of ADHD, in June 2020.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/inquire-before-buying

(Inquire a report quote OR available discount offers to the sales team before purchase.)

Digital therapeutics is anticipated to rise at a steady pace in the given timeframe, due to strong internet usage and reliance on smartphones. This is due to a rise in demand for creative and innovative treatment solutions that patients can access remotely.

In February 2021, SilverCloud and Cerner Corporation collaborated to combine SilverCloud's virtual mental health network with Cerner's electronic health records. SilverCloud hoped that by doing so, it would be able to scale the delivery of evidence-based mental health services while both enhancing patient outcomes and lowering healthcare costs.

Browse detail report with in-depth TOC @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market

Polaris Market Research has segmented the digital therapeutics market report based on application, end-use, and region:

Digital Therapeutics, Application Outlook (Revenue - USD Billion, 2016 - 2028)

Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others

Digital Therapeutics, End-Use Outlook (Revenue - USD Billion, 2016 - 2028)

Patients
Providers
Payers
Employers
Others

Contact Us:
Polaris Market Research
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Ph: +1-929 297-9727

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

This release was published on openPR.